Brett Williams, MD

1. Collaco AM, Rahman S, Dougherty EJ, Williams BB, Geusz ME
Circadian regulation of a viral gene promoter in live transgenic mice expressing firefly
luciferase.
Mol Imaging Biol. 2005 Sep-Oct;7(5):342-50

2. Williams BB, Hanson A, Sha B. (2014)
 A case of diffuse desquamating rash following exposure to vancomycin impregnated bone cement. 
Ann Pharmacother. 2014 Apr 16;48(8):1061-1065.

3. Williams B, Livak B, Bahk M, Keating SM, Adeyemi OM. SCD14 and SCD163 Levels Are Correlated with VACS Index Scores: Initial Data from the Blunted Immune Recovery in CORE Patients with HIV (BIRCH) Cohort. AIDS Res Hum Retroviruses. 2015 Sep 14;PubMed PMID: 26366931.

4.  Hodowanec A, Williams B, Hanson B, Livak B, Keating S, Lurain N, Adeyemi O.
Soluble CD163 But Not Soluble CD14 Is Associated With Cytomegalovirus Immunoglobulin G Antibody Levels in Virologically Suppressed HIV+ Individuals. 
J Acquir Immune Defic Syndr (Accepted September 2015)

5. Williams B, Landay A, Presti R. Microbiome alterations in HIV Infection, a review. Cell Microbiol Mar 6. doi: 10.1111/cmi.12588. [Epub ahead of print]

6. Williams B, Mirmonsef P, Boucher CA, Bushman F, Carrington-Lawrence S, et al. A Summary of The First HIV Microbiome Workshop 2015. AIDS Res Hum Retroviruses. 2016 Jun 7;PubMed PMID: 27267576.

7. Liu J,  Williams B, Frank D, Dillon SM, Wilson C, and Alan L. Landay.  Inside Out: HIV, the Gut Microbiome, and the Mucosal
Immune System. J Immunol. 2017 Jan 15;198(2):605-614. 

8. Boctor N, Nguyen D, Williams B. Pasteurella multocida cardiovascular implantable electronic device infection with recurrent bacteremia: a case report. Infectious Diseases in Clinical Practice. June 15 2017

9. Williams B, Ghosh M, Boucher CAB, Bushman F, Carrington-Lawrence S, et al. A Summary of the Second Annual HIV Microbiome Workshop. AIDS Res Hum Retroviruses. 2017 Dec;33(12):1258-1264. PubMed PMID: 28899105; PubMed Central PMCID: PMC5770117.

A5346 - A Randomized, Double-Blinded, Placebo-Controlled Trial of a Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin, Januvia) for Reducing Inflammation and Immune Activation in HIV-Infected Men and Women

A5350 - Safety, Tolerability and Effects of the Probiotic VISBIOME Extra Strength on Gut Microbiome and Immune Activation Markers in HIV-infected Participants on Suppressive Antiretroviral Therapy: A Phase II Study

A5369 - HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) as Therapeutic Vaccination in HIV-Infected Persons with Viral Suppression on Antiretroviral Therapy

1. Review of the first HIV Microbiome conference
Inflammation Transformative Science Group of the ACTG. June 25th 2015

2. Wee beasties, our besties. The role of the microbiome in HIV infection
Midwest AIDS Training and Education Center. April 6th 2016

3. Update on HIV for the generalist
West Suburban Medical Center, Oak Park IL, Grand Rounds
April 26th, 2017 

4. An update on HIV therapy
Saint Elizabeth’s/Saint Mary’s Medical Center, Chicago IL, Grand rounds
July 11th, 2017

5. An update on HIV
Thorek Hospital, Chicago IL, Grand rounds
May 3rd, 2018